« Back
Home /
CGP 3466B maleate

CGP 3466B maleate

Item no.	TMO-T21792-2mg
Manufacturer	TargetMol
CASRN	200189-97-5
Amount	2mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitor
Specific against	other
Purity	0,98
Smiles	C(=C\C(O)=O)\C(O)=O.C(N(CC#C)C)C=1C=2C(OC=3C(C1)=CC=CC3)=CC=CC2
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Apoptosis, Omigapil (Maleate) , Omigapil maleate
Available
Short Description	CGP 3466B maleate (Omigapil maleate) is an orally bioavailable GAPDH nitrosylation inhibitor. Omigapil maleate abrogates Aβ1-42-induced tau acetylation, memory impairment, and locomotor dysfunction in mice. Omigapil maleate has the potential for the research of Alzheimer's disease. Omigapil maleate (CGP3446B maleate) is a apoptosis inhibitor. Omigapil maleate can be used for the research of congenital muscular dystrophy (CMD).
Shipping	cool pack
Storage	-20°
Target names or alias	Omigapil (Maleate) , Omigapil maleate
Molecular Weight	391, 42
Pathway	Apoptosis
Target	Apoptosis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 2mg

available

Delivery expected until 8/30/2024

Express Delivery: Save 4 days

Compare

Add to wishlist

Recommend by mail